<DOC>
	<DOCNO>NCT00893581</DOCNO>
	<brief_summary>Specific Aim 1 : To determine effect treatment quetiapine lithium brain activation adolescent . The investigator use functional magnetic resonance imaging ( fMRI ) examine brain activation attentional task . Specific Aim 2 : To determine effect treatment quetiapine lithium neurometabolite measure , early illness course . The investigator use 1H-MRS identify myo-inositol ( mI ) , N-acetyl aspartate ( NAA ) , glutamate ( Glu ) level prefrontal ALN region . Specific Aim 3 : To determine relationship among change brain activation neurometabolite measure , well symptomatic improvement manic adolescent .</brief_summary>
	<brief_title>Multimodal Neuroimaging Treatment Effects Adolescent Mania</brief_title>
	<detailed_description>Hypotheses 1 &amp; 2 predict follow 6 week treatment lithium quetiapine , manic adolescent demonstrate symptomatic improvement exhibit normalize ( decrease ) VLPFC ACC activation increase activation compensatory posterior attentional brain area well normalization VLPFC ACC neurometabolite measure ( increase NAA decrease Glu level ) compare experience symptomatic improvement healthy adolescent . Hypothesis 3 predicts significant association fMRI activation change ( i.e . decrease activation VLPFC ACC ROIs increase activation posterior attention ROI ) MRS change ( increase NAA decrease Glu level VLPFC ACC ) patient exhibit symptomatic improvement either treatment . Hypothesis 4 predicts decrease mI level 1 week associate lithium , quetiapine , response endpoint . In contrast , Hypothesis 5 predict high baseline Cho level associate quetiapine , lithium , response endpoint .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Inclusion/Exclusion Criteria Inclusion Bipolar Disorder Subjects : DSMIVTR12 criterion bipolar disorder , type I , manic mixed episode , diagnose Washington University St. Louis Kiddie Schedule Affective Disorders Schizophrenia ( WASHUKSADS ) 166,101,102103,104105,108 Baseline YMRS112114 score &gt; 20 ; Ages 1217 year 11 month old ; Fluent English ; Provision write informed consent legal guardian write assent subject ; Tanner scale stage IIIV167 , order include postpubescent subject minimize brain change associate onset puberty ; 168169 Less 2 year onset bipolar disorder , define age onset first DSMIVTR affective episode ( mania , hypomania , depression mixed ) , establish sample early illness course ; No prior psychiatric hospitalization , &lt; 3 month lifetime psychotropic medication exposure ( exception psychostimulants , since exclude patient psychostimulant exposure would significantly limit generalizability finding ) , active psychotropic medication week ( 72 hour psychostimulants benzodiazepine ) prior index assessment ( treatment fluoxetine prior month ) . Please note patient NOT take medication purpose study ; instead , criterion exclude subject receive treatment time index assessment ; Does history intolerance nonresponse lithium quetiapine ; Manic depressive symptom result entirely acute medical illness acute intoxication withdrawal drug alcohol determine medical evaluation rapid symptom resolution ; No lifetime DSMIVTR diagnosis posttraumatic stress disorder ( PTSD ) , since PTSD associate abnormality prefrontal NAA function170171,172 . Furthermore , bipolar patient cooccurring PTSD less likely respond lithium monotherapy , often need serotonin specific reuptake inhibitor ( SSRI ) adjunctive treatment mood stabilizer.173,174 ; If female child bear potential , agree use one follow method birth control : complete abstinence sexual intercourse , barrier ( diaphragm condom ) , oral/injectable contraceptive . Inclusion Healthy Controls : Ages 1217 year 11 month ; No history DSMIVTR Axis I disorder ( nicotine dependence permit ) ; No first seconddegree relative affective psychotic disorder ; No medication central nervous system effect within 5 halflives ; Fluent English ; Tanner stage IIIV ; Provision inform consent assent . Exclusion Bipolar Subjects &amp; Healthy Controls : Contraindication MRI scan ( e.g. , brace claustrophobia ) ; An unstable medical neurological illness could influence fMRI MRS result ; IQ &lt; 70 , determine The Wechsler Abbreviated Scale Intelligence ( WASI ) ; A positive pregnancy test ; A history major medical neurological illness significant episode ( &gt; 10 minute ) loss consciousness ; Any lifetime DSMIVTR substance use disorder ( nicotine dependence permit ) ; A lifetime DSMIVTR diagnosis pervasive developmental disorder ; The patient live &gt; 100 mile University Cincinnati able attend followup visit .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>mania</keyword>
	<keyword>adolescent</keyword>
	<keyword>bipolar</keyword>
</DOC>